Concerns are increasing in the EU about the use of chemicals employed in the manufacture of the recreational drug GHB. The report GHB and its precursor GBL: an emerging trend case study is published as part of the EMCDDA's E-POD project to track new patterns of drug use in Europe. GHB is a compound which occurs naturally in the body, but is also a medicinal product and arecreational drug. Non-medical use of GHB is reported to have begun in the 1980s by body builders. Use of GHB surfaced on therecreational nightlife scene in some parts of Europe, USA and Australia during the 1990s, specifically in night clubs where many other drugs were being commonly used. Concerns quickly arose about the health risks associated with its use. In particular, anxieties arose about the potential for surreptitiously adding GHB to drinks (commonly referred to as 'drink spiking') to facilitate sexual assault.
"synopsis" may belong to another edition of this title.
(No Available Copies)
If you know the book but cannot find it on AbeBooks, we can automatically search for it on your behalf as new inventory is added. If it is added to AbeBooks by one of our member booksellers, we will notify you!Create a Want